Eva Domingo-Domenech (E Domingo-Domenech, E Domingo-Domènech)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 18

Top Venues

Blood advances

Bone marrow transplantation

Antibiotics (Basel, Switzerland)

Cancers

Institut Catala d'Oncologia

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institut Catala d'Oncologia May 01 2000

Spain

Jefe Clinico :: Hematologia

Publications

Thomas E Witzig, Lubomir Sokol, Won Seog Kim, Fátima de la Cruz Vicente, Alejandro Martin Martin Garcia-Sancho, Ranjana Advani, Jose Maria Roncero Vidal, Raquel de Oña Navarrete, Ana Marín-Niebla, Antonia Rodriguez Izquierdo, Maria José Terol, Eva Domingo-Domenech, Andrew Saunders, Nawal Bendris, Julie Mackey, Mollie Leoni, Francine M Foss
Phase 2 trial of the farnesyltransferase inhibitor tipifarnib for relapsed/refractory peripheral T-cell lymphoma. Blood advances 8 (17) (2024)
Pier Luigi Luigi Zinzani, Gilles Andre Salles, Alison J Moskowitz, Armando Santoro, Amitkumar Mehta, Paul M Barr, Neha Mehta-Shah, Graham P Collins, Stephen M Ansell, Joshua D Brody, Eva Domingo-Domenech, Nathalie A Johnson, David Cunningham, Silvia Ferrari, Julie Lisano, Jennifer Krajewski, Rachael Wen, Alev Akyol, Russell Crowe, Kerry Joane Savage
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma. Blood advances 8 (10) (2024)
Pier Luigi Luigi Zinzani, Gilles Andre Salles, Alison J Moskowitz, Armando Santoro, Amitkumar Mehta, Paul M Barr, Neha Mehta-Shah, Graham P Collins, Stephen M Ansell, Joshua D Brody, Eva Domingo-Domenech, Nathalie A Johnson, David Cunningham, Silvia Ferrari, Julie Lisano, Jennifer Krajewski, Rachael Wen, Alev Akyol, Russell Crowe, Kerry Joane Savage
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma. Blood advances 8 (10) (2024)
Pier Luigi Luigi Zinzani, Gilles Andre Salles, Alison J Moskowitz, Armando Santoro, Amitkumar Mehta, Paul M Barr, Neha Mehta-Shah, Graham P Collins, Stephen M Ansell, Joshua D Brody, Eva Domingo-Domenech, Nathalie A Johnson, David Cunningham, Silvia Ferrari, Julie Lisano, Jennifer Krajewski, Rachael Wen, Alev Akyol, Russell Crowe, Kerry Joane Savage
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma. Blood advances 8 (10) (2024)
Pier Luigi Luigi Zinzani, Gilles Andre Salles, Alison J Moskowitz, Armando Santoro, Amitkumar Mehta, Paul M Barr, Neha Mehta-Shah, Graham P Collins, Stephen M Ansell, Joshua D Brody, Eva Domingo-Domenech, Nathalie A Johnson, David Cunningham, Silvia Ferrari, Julie M Lisano, Jennifer Krajewski, Rachael Wen, Alev Akyol, Russell Crowe, Kerry Joane Savage
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma. Blood advances (2024)
Thomas E Witzig, Lubomir Sokol, Won Seog Kim, Fátima de la Cruz, Alejandro Martin Martin Garcia-Sancho, Ranjana H Advani, Josep Maria Roncero Vidal, Raquel De Oña, Ana Marin-Niebla, Antonia Rodriguez Izquierdo, Maria José Terol, Eva Domingo-Domenech, Andrew Saunders, Nawal Bendris, Julie Mackey, Mollie Leoni, Francine M Foss
Phase 2 Trial of the Farnesyltransferase Inhibitor Tipifarnib for Relapsed/Refractory Peripheral T Cell Lymphoma. Blood advances (2024)
Thomas E Witzig, Lubomir Sokol, Won Seog Kim, Fátima de la Cruz Vicente, Alejandro Martin Martin Garcia-Sancho, Ranjana Advani, Jose Maria Roncero Vidal, Raquel de Oña Navarrete, Ana Marín-Niebla, Antonia Rodriguez Izquierdo, Maria José Terol, Eva Domingo-Domenech, Andrew Saunders, Nawal Bendris, Julie Mackey, Mollie Leoni, Francine M Foss
Phase 2 trial of the farnesyltransferase inhibitor tipifarnib for relapsed/refractory peripheral T-cell lymphoma. Blood advances 8 (17) (2024)
Pier Luigi Luigi Zinzani, Gilles Andre Salles, Alison J Moskowitz, Armando Santoro, Amitkumar Mehta, Paul M Barr, Neha Mehta-Shah, Graham P Collins, Stephen M Ansell, Joshua D Brody, Eva Domingo-Domenech, Nathalie A Johnson, David Cunningham, Silvia Ferrari, Julie Lisano, Jennifer Krajewski, Rachael Wen, Alev Akyol, Russell Crowe, Kerry Joane Savage
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma. Blood advances 8 (10) (2024)
Valeria Castelli, Enric Sastre-Escolà, Pedro Puerta-Alcalde, Leyre Huete-Álava, Júlia Laporte-Amargós, Alba Bergas, Mariana Chumbita, Mar Marín, Eva Domingo-Domenech, Ana María Badia-Tejero, Paula Pons-Oltra, Carolina García-Vidal, Jordi Carratala, Carlota Gudiol
The Etiology, Antibiotic Therapy and Outcomes of Bacteremic Skin and Soft-Tissue Infections in Onco-Hematological Patients. Antibiotics (Basel, Switzerland) 12 (12) (2023)
Marta Grau, Cristina López, Alba Navarro, Gerard Frigola, Ferran Nadeu, Guillem Clot, Gabriela Bastidas, Miguel Alcoceba, Maria Joao Baptista, Margarita Blanes, Dolors Colomer, Dolors Costa, Eva Domingo-Domenech, Anna Enjuanes, Lourdes Escoda, Pilar Forcada, Eva Gine, Monica Lopez-Guerra, Olga Ramón, Alfredo Rivas-Delgado, Laura Vicente-Folch, Andrew Wotherspoon, Fina Climent, Elias Campo, Armando López-Guillermo, Estella Matutes, Sílvia Beà
Unraveling the genetics of transformed splenic marginal zone lymphoma. Blood advances (2023)
Valeria Castelli, Enric Sastre-Escolà, Pedro Puerta-Alcalde, Leyre Huete-Álava, Júlia Laporte-Amargós, Alba Bergas, Mariana Chumbita, Mar Marín, Eva Domingo-Domenech, Ana María Badia-Tejero, Paula Pons-Oltra, Carolina García-Vidal, Jordi Carratala, Carlota Gudiol
The Etiology, Antibiotic Therapy and Outcomes of Bacteremic Skin and Soft-Tissue Infections in Onco-Hematological Patients. Antibiotics (Basel, Switzerland) 12 (12) (2023)
Marta Peña, C Montané, A Paviglianiti, L Hurtado, S González, I Carro, C Maluquer, Eva Domingo-Domenech, Eva González-Barca, A Sureda, A Mussetti
Outcomes of allogeneic hematopoietic cell transplantation after bispecific antibodies in non-Hodgkin lymphomas. Bone marrow transplantation (2023)
Carla Marco, Ariadna Padró-Miquel, Eva Domingo-Domenech, Roser Velasco
Comment on: Brentuximab vedotin-related neuropathy in a patient with Gilbert syndrome: Do mutations of UGT1A1 gene affect brentuximab toxicity? Pediatric blood & cancer (2023)
Kerry Joane Savage, Steven M Horwitz, Ranjana Advani, Jacob Haaber Christensen, Eva Domingo-Domenech, Giuseppe Rossi, Judith Trotman, Onder Alpdogan, Cheolwon Suh, Kensei Tobinai, Andrei Shustov, Marek Trněný, Sam Yuen, Pier Luigi Luigi Zinzani, Lorenz Trümper, Tim Ilidge, Owen A O'Connor, Barbara Pro, Harry Miao, Veronica Bunn, Keenan Fenton, Michelle Fanale, Markus Puhlmann, Swaminathan Iyer
Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2. Blood advances 6 (19) (2022)
Rocio Parody, I Sánchez-Ortega, A Mussetti, B Patiño, M Arnan, H Pomares, Eva González-Barca, S Mercadal, C Boqué, C Maluquer, I Carro, M Peña, V Clapés, S Verdesoto, G Bustamante, A C Oliveira, C Baca, E Cabezudo, C Talarn, L Escoda, S Ortega, N García, M Isabel González-Medina, Mar Sánchez-Salmerón, C Fusté, J Villa, E Carreras, Eva Domingo-Domenech, A Sureda
A real-life overview of a hematopoietic cell transplant program throughout a four-year period, including prospective registry, exclusion causes and final donor selection. Bone marrow transplantation (2021)
Roser Velasco, Eva Domingo-Domenech, Anna Sureda
Brentuximab-Induced Peripheral Neurotoxicity: A Multidisciplinary Approach to Manage an Emerging Challenge in Hodgkin Lymphoma Therapy. Cancers 13 (23) (2021)
Eva Domingo-Domenech, R F Duarte, A Boumedil, F Onida, I Gabriel, H Finel, William Arcese, P Browne, D Beelen, G Kobbe, H Veelken, R Arranz, H Greinix, S Lenhoff, Xavier Poire, J M Ribera, J Thompson, Tsila Zukerman, G J Mufti, A Cortelezzi, E Olavarria, Peter Dreger, A Sureda, S Montoto
Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation. Bone marrow transplantation 56 (6) (2021)
Maria Condom, Fina Climent, Davinia Fernández, Dolors Colomer, Mónica Lopez-Guerra, Mar Varela, Itziar Carro, Clara Maluquer, Santiago Mercadal, Ana Carla Oliveira, Maria Pané, Xavier Matias-Guiu, Eva González-Barca, Anna Sureda, Eva Domingo-Domenech
Clonal relationship in multisited mucosa-associated lymphoid tissue lymphomas: a single-centre experience. British journal of haematology 192 (6) (2020)

Eva Domingo-Domenech.css-eqlu8i{font-size:small;padding-left:4px;} (E Domingo-Domenech, E Domingo-Domènech)

Publication Activity (10 Years)

Top Topics

Top Venues

Eva Domingo-Domenech (E Domingo-Domenech, E Domingo-Domènech)